What a Brooklyn bodega reveals about the craze for an experimental weight-loss drug

A local Brooklyn bodega has started selling an experimental weight-loss drug called retatrutide, which hasn't been approved by the FDA. This surprising discovery highlights the growing demand for weight-loss solutions, even if they haven't been officially sanctioned. It raises significant questions about safety and regulation in the pharmaceutical market, as well as the lengths people will go to in pursuit of effective weight-loss treatments. This situation underscores the urgent need for clearer oversight in the distribution of unapproved drugs.